Urbanisation of yellow fever in Santa Cruz, Bolivia

Lancet

Volumn 353, Issue 9164, 1999, Pages 1558-1562

  Van Der Stuyft, P ^a   Gianella, A ^b   Pirard, M ^c   Cespedes, J ^d   Lora, J ^b   Peredo, C ^b   Pelegrino, J L ^e   Vorndam, V ^f   Boelaert, M ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Ctro Nac de Enfermed Tropicales   (Bolivia)

^c Belg Agy for Devmt Co operation   (Bolivia)

^d Dir Departamental de Salud   (Bolivia)

^e INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ADULT; AEDES AEGYPTI; ARTICLE; BOLIVIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DENGUE; HEPATITIS A; HEPATITIS B; HUMAN; LEPTOSPIROSIS; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; YELLOW FEVER;

EID: 0033535776     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03291-2     Document Type: Article

References (20)

1. Brès P.L.J. A century of progress in combating yellow fever. Bull World Health Organ. 64:1986;775-786.
2. Robertson S.E., Hull B.P., Tomori O., Bele O., LeDuc J.W., Esteves K. Yellow fever: a decade of reemergence. JAMA. 276:1996;1157-1162.
3. Anon. Yellow fever, 1996-1997 (part 1). Wkly Epidemiol Rec 1998; 73: 354-59.
4. Monath T.P. Yellow fever: Victor, victoria? Conqueror, conquest? Epidemics and research in the last forty years and prospects for the future. Am J Trop Med Hyg. 45:1991;1-43.
5. Schofield C.J., Hemingway J., Balderrama S. Insecticide resistance in Bolivian Aedes aegypti. Bol Cient CENETROP. 10:1984;22-28.
6. Pan American Health Organization. Dengue and dengue hemorrhagic fever in the Americas: guidelines for prevention and control. Washington: Scientific Publication no 548, 1994: 1-98.
7. Van der Stuyft P., Gianella A., Pirard M.et al. Dengue serotype 2 subtype III (Jamaica) epidemic in Santa Cruz, Bolivia. Trop Med Int Health. 3:1998;857-858.
8. Present status of yellow fever: memorandum from a PAHO Meeting. Bull World Health Organ. 64:1986;511-524.
9. Vargas Sagarnaga R. Estado de la fiebre amarilla selvatica en Bolivia. Bol Cient CENETROP. 9:1983;13-20.
10. Anon. Yellow fever, Bolivia, outbreak news. Wkly Epidemiol Rec 1999; 74: 56.
11. Watts D.M., Lavera V., Callahan J.et al. Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am J Trop Med Hyg. 56:1997;661-667.
12. World Health Organization. District guidelines for yellow fever surveillance. Geneva: WHO Expanded Programme on Immunization, 1998 (WHO/EPI/GEN/98·09).
13. Innis B.L., Nisalak A., Nimmannitya S.et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg. 40:1989;418-427.
14. Chippaux A., Deubel V., Moreau J.P., Reynes J.M. Situation actuelle de la fièvre jaune en Amérique latine. Bull Soc Pathol Exot. 86:1993;460-464.
15. Soper F.L. The elephant never forgets. Am J Trop Med Hyg. 1:1952;361-368.
16. Anon. Yellow fever in Bolivia. Lancet 1999; 353: 648.
17. Anon. Yellow fever, Bolivia. Wkly Epidemiol Rec 1999; 74: 80.
18. Monath T.P., Nasidi A. Should yellow fever vaccination be included in the Expanded Program of Immunization in Africa? A cost-effectiveness analysis for Nigeria. Am J Trop Med Hyg. 48:1993;274-299.
19. Anon. Yellow fever, 1996-1997 (part 2). Wkly Epidemiol Rec 1998; 73: 370-72.
20. Robertson R.L., Hall A.J., Crivelli P.E., Lowe Y., Inskip H.M., Snow S.K. Cost-effectiveness of immunizations: The Gambia revisited. Health Pol Plann. 7:1992;111-122.